These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 30874403)

  • 41. Anticoagulation for Nonvalvular Atrial Fibrillation: Influence of Epidemiologic Trends and Clinical Practice Patterns on Risk Stratification and Net Clinical Benefit.
    Asinger RW; Shroff GR; Simegn MA; Herzog CA
    Circ Cardiovasc Qual Outcomes; 2017 Sep; 10(9):. PubMed ID: 28893833
    [No Abstract]   [Full Text] [Related]  

  • 42. Screening for atrial fibrillation above age 65 detects an asymptomatic subset at high risk of stroke.
    Deif B; Lowres N; Freedman SB
    Int J Cardiol; 2013 Apr; 164(3):371-2. PubMed ID: 22964080
    [No Abstract]   [Full Text] [Related]  

  • 43. Under-use of warfarin for patients with non-valvular atrial fibrillation in Japan.
    Inoue H
    Intern Med; 2004 Jul; 43(7):529-30. PubMed ID: 15335173
    [No Abstract]   [Full Text] [Related]  

  • 44. Device-identified atrial fibrillation at pacing clinics. Should it guide anticoagulation?
    Merinopoulos I; Raphael CE; Yardley A; Goonewardene M; Vassiliou VS
    Int J Cardiol; 2016 Mar; 207():378-81. PubMed ID: 26826369
    [TBL] [Abstract][Full Text] [Related]  

  • 45. SAMe-TT2R2 Score: Useful in All Patients With Nonvalvular Atrial Fibrillation?
    Escobar C; Barrios V; Lobos JM; Prieto L
    Rev Esp Cardiol (Engl Ed); 2016 Aug; 69(8):798. PubMed ID: 27328996
    [No Abstract]   [Full Text] [Related]  

  • 46. Efficacy and safety of apixaban in patients after cardioversion for atrial fibrillation: insights from the ARISTOTLE Trial (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation).
    Flaker G; Lopes RD; Al-Khatib SM; Hermosillo AG; Hohnloser SH; Tinga B; Zhu J; Mohan P; Garcia D; Bartunek J; Vinereanu D; Husted S; Harjola VP; Rosenqvist M; Alexander JH; Granger CB;
    J Am Coll Cardiol; 2014 Mar; 63(11):1082-7. PubMed ID: 24211508
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Therapy of atrial fibrillation].
    Hoffmann BA; Rostock T; Drewitz I; Steven D; Willems S
    MMW Fortschr Med; 2009 Nov; 151(47):58-62; quiz 63. PubMed ID: 20037981
    [No Abstract]   [Full Text] [Related]  

  • 48. Stroke risk in atrial fibrillation: Do we anticoagulate CHADS2 or CHA2DS2-VASc ≥1, or higher?
    Olesen JB; Torp-Pedersen C
    Thromb Haemost; 2015 Jun; 113(6):1165-9. PubMed ID: 25743201
    [No Abstract]   [Full Text] [Related]  

  • 49. SAMe-TT2R2 Score: Useful in All Patients With Nonvalvular Atrial Fibrillation? Response.
    Andreu-Cayuelas JM; Puche CM; Flores-Blanco PJ; Manzano-Fernández S
    Rev Esp Cardiol (Engl Ed); 2016 Aug; 69(8):799. PubMed ID: 27328997
    [No Abstract]   [Full Text] [Related]  

  • 50. Feasibility of extended ambulatory electrocardiogram monitoring to identify silent atrial fibrillation in high-risk patients: the Screening Study for Undiagnosed Atrial Fibrillation (STUDY-AF).
    Turakhia MP; Ullal AJ; Hoang DD; Than CT; Miller JD; Friday KJ; Perez MV; Freeman JV; Wang PJ; Heidenreich PA
    Clin Cardiol; 2015 May; 38(5):285-92. PubMed ID: 25873476
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Screening for Atrial Fibrillation with Electrocardiography.
    Tracer H; Welch R
    Am Fam Physician; 2019 Mar; 99(6):383-384. PubMed ID: 30874416
    [No Abstract]   [Full Text] [Related]  

  • 52. Stroke Risk Status, Anticoagulation Treatment, and Quality-of-Life in Chinese Patients with Atrial Fibrillation: China Registry of Atrial Fibrillation (CRAF).
    Sun Y; Zhu J; Ma C; Liu S; Yang Y; Hu D
    Cardiovasc Ther; 2019; 2019():7372129. PubMed ID: 31772614
    [No Abstract]   [Full Text] [Related]  

  • 53. High-intensity atrial fibrillation screening to prevent stroke.
    Freedman B; Lowres N
    Lancet; 2021 Oct; 398(10310):1465-1467. PubMed ID: 34469760
    [No Abstract]   [Full Text] [Related]  

  • 54. [Atrial fibrillation: drug, interventional or surgical treatment? For drug treatment].
    Lewalter T
    Dtsch Med Wochenschr; 2010 Apr; 135(13):612. PubMed ID: 20333589
    [No Abstract]   [Full Text] [Related]  

  • 55. Clinical practice. Newly diagnosed atrial fibrillation.
    Page RL
    N Engl J Med; 2004 Dec; 351(23):2408-16. PubMed ID: 15575057
    [No Abstract]   [Full Text] [Related]  

  • 56. Population-based evaluation of the management of antithrombotic therapy for atrial fibrillation.
    Anderson DR; Gardner MJ; Putnam W; Jassal D; Brownell B; Flowerdew G; Nagpal S; Thompson K; Cox JL
    Can J Cardiol; 2005 Mar; 21(3):257-66. PubMed ID: 15776115
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Feasibility and cost-effectiveness of stroke prevention through community screening for atrial fibrillation using iPhone ECG in pharmacies. The SEARCH-AF study.
    Lowres N; Neubeck L; Salkeld G; Krass I; McLachlan AJ; Redfern J; Bennett AA; Briffa T; Bauman A; Martinez C; Wallenhorst C; Lau JK; Brieger DB; Sy RW; Freedman SB
    Thromb Haemost; 2014 Jun; 111(6):1167-76. PubMed ID: 24687081
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacy-based screening for atrial fibrillation in high-risk Maori and Pacific populations.
    Walker N; Doughty R; Parag V; Harrison J; Bennett M; Freedman B
    N Z Med J; 2014 Jul; 127(1398):128-31. PubMed ID: 25146870
    [No Abstract]   [Full Text] [Related]  

  • 59. Quantifying Time in Atrial Fibrillation and the Need for Anticoagulation.
    Miyazawa K; Pastori D; Lip GYH
    Prog Cardiovasc Dis; 2018; 60(4-5):537-541. PubMed ID: 29289494
    [TBL] [Abstract][Full Text] [Related]  

  • 60. MY APPROACH to the practical management of anticoagulation in patients with atrial fibrillation.
    Flaker G
    Trends Cardiovasc Med; 2016 Apr; 26(3):292. PubMed ID: 26874917
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.